Statistics

Total Visits

Views
Phase II Trial of Erlotinib plus Capecitabine as First-line Treatment for Metastatic Pancreatic Cancer (XELTA Study)99

Select a period of time:

Number of views in the range

Views
Phase II Trial of Erlotinib plus Capecitabine as First-line Treatment for Metastatic Pancreatic Cancer (XELTA Study)36

Views

Views
August 20253
September 20256
October 20253
November 20254
December 202510
January 202610
February 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Brazil7
United Kingdom4
Singapore2
Argentina1
Austria1
Colombia1
France1
Mexico1
Turkey1
 

Top cities views

Views
Ashburn5
San Jose3
Contendas do Sincorá1
Dallas1
Itatiba1
Jaguariúna1
Los Angeles1
Mar del Plata1
Monterrey1
Pelotas1